1
Syed M Waheed
Bhatnagar Rakesh, Waheed Syed Mohsin, Chauhan Vibha: High level constitutive production of anthrax protective antigen. Bhatnagar Rakesh, Waheed Syed Mohsin, Chauhan Vibha, GUPTA Bhartee, May 15, 2003: WO/2003/040179

The present invention relates to a process for preparing anthrax protective antigen protein from E.coli using fed batch culture. This process creates a constitutively expressing system for rapid, efficient, cost-effective and high-level production of anthrax PA from E.coli. The steps of the process ...


2
Bhatnagar Rakesh, Waheed Syed Moshin, Chauhan Vibha: High level constitutive production of anthrax protective antigen. Bhatnagar Rakesh, Waheed Syed Moshin, Chauhan Vibha, August 4, 2004: EP1442052-A1

The present invention relates to a process for preparing anthrax protective antigen protein from E.coli using fed batch culture. This process creates a constitutively expressing system for rapid, efficient, cost-effective and high-level production of anthrax PA from E.coli. The steps of the process ...


3
Bhatnagar Rakesh, Gupta Pankaj, Batra Smriti, Chauhan Vibha, Singh Aparna, Ahuja Nidhi, Kumar Praveen: A process for the preparation of a non-toxic anthrax vaccine. Bhatnagar Rakesh, Gupta Pankaj, Batra Smriti, Chauhan Vibha, Singh Aparna, Ahuja Nidhi, Kumar Praveen, ANAND Pravin, June 12, 2003: WO/2003/048390

Anthrax toxin, comprising of protective antigen (PA), lethal factor (LF) and edema factor (EF) is a major virulent factor of B.anthracis. Protective antigen, PA is the main component of all the vaccines against anthrax. The protective efficacy of PA is greatly increased if small quantities of LF or ...



Click the thumbnails below to visualize the patent trend.